Press Releases Elutia Inc.

Equities

ELUT

US05479K1060

Real-time Estimate Cboe BZX Other stock markets 18:17:08 03/05/2024 BST			5-day change	1st Jan Change
2.955 ^USD	+5.54%		+6.83%	+37.50%

03-07	Transcript : Elutia Inc., Q4 2023 Earnings Call, Mar 07, 2024
03-07	Elutia Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024	05-02	AQ
Elutia Planet MicroCap Showcase: VEGAS 2024 Presentation	05-02	PU
Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1	04-24	AQ
Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024	03-07	AQ
Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024	02-22	AQ
Elutia's CanGarooRM: Pioneering Drug-Eluting Biologic for Secure Medical Implants	02-20	AQ
Elutia Regains Compliance with Nasdaq Listing Requirements	01-10	AQ
Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance	12-18	AQ
Elutia : The Wall Street Transcript	12-04	PU
Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial Results	11-13	AQ
Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million	11-09	AQ
Elutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023	11-06	AQ
Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices	06/09/23	AQ
Aziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative Procedures	30/08/23	AQ
Aziyo Biologics : 2Q 2023 Financial Results Presentation	15/08/23	PU
Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix Company	14/08/23	AQ
Aziyo Biologics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023	31/07/23	AQ
Aziyo Biologics Announces Voluntary Recall of Viable Bone Matrix Products	13/07/23	AQ
Aziyo Biologics : Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - Form 8-K	09/06/23	PU
Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic Envelope	19/05/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Elutia Inc.

Equities

ELUT

US05479K1060

Press Releases

Filters